Hope, but also danger: More cancer patients are flying to China for treatment

China is attracting more foreign cancer patients seeking CAR-T treatment, drawn by lower costs and advances in biotechnology.

The therapy is cheaper in China than in Western countries, making the country an increasingly popular destination for patients looking for access to the treatment.

Chinese regulators have recently approved nine CAR-T products, more than any other country. The list includes the first approved CAR-T therapy for solid tumors, offering new hope while also raising concerns about the risks involved.